Home

Fredun Pharmaceuticals Ltd EPS

Image

Fredun Pharmaceuticals Ltd

NSE: FREDUNPHARMA

EPS

₹ 39.81

Last updated on: Apr 22, 2025

Key Highlights

  • The Earning per Share of Fredun Pharmaceuticals Ltd is ₹ 39.81 as of 22 Apr 25 .
  • The earning per share of Fredun Pharmaceuticals Ltd changed from ₹ 5.24 to ₹ 11.29 over 7 quarters. This represents a CAGR of 55.06% .

Historical Earning per Share of Fredun Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for Fredun Pharmaceuticals Ltd

Market Cap

321 Cr

EPS

39.8

P/E Ratio (TTM)

17.1

P/B Ratio (TTM)

2.5

Day’s High

689.0

Day’s Low

660.0

DTE

1.0

ROE

13.5

52 Week High

1024.0

52 Week Low

635.0

ROCE

15.7

Market Price of Fredun Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Fredun Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Apr 2025681.75
21 Apr 2025675.35
17 Apr 2025667.95
16 Apr 2025670.8
15 Apr 2025677.25
11 Apr 2025653.8
09 Apr 2025645.1
08 Apr 2025665.15
07 Apr 2025668.95
04 Apr 2025706.2

SWOT Analysis Of Fredun Pharmaceuticals Ltd

Strength

1

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Fredun Pharmaceuticals Ltd

Asset Value vs Market Value of Fredun Pharmaceuticals Ltd

Market Value

322

Asset Value

Value addition

0.3 X

256

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Fredun Pharmaceuticals Ltd321.9
Sun Pharmaceutical Industries Ltd419224
Divis Laboratories Ltd157046
Cipla Ltd123412
Torrent Pharmaceuticals Ltd109829
Mankind Pharma Ltd106262

Historical Market Cap of Fredun Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Fredun Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Fredun Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Fredun Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Fredun Pharmaceuticals Ltd News Hub

Fredun Pharmaceuticals AGM scheduled

Fredun Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held o

Read more

19 Sept 24

Fredun Pharmaceuticals to hold AGM

Fredun Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held o

Read more

19 Sept 24

Fredun Pharmaceuticals to hold board meeting

Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 3 October 202

Read more

27 Sept 24

Fredun Pharmaceuticals to discuss results

Fredun Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 26 October 20

Read more

16 Oct 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Fredun Pharmaceuticals Ltd

What is the EPS of Fredun Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of Fredun Pharmaceuticals Ltd is 39.81. An EPS is the amount of net income attributed to each share of a common stock.

How is Fredun Pharmaceuticals Ltd EPS calculated?

The EPS of Fredun Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Fredun Pharmaceuticals Ltd report its EPS?

Fredun Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Fredun Pharmaceuticals Ltd EPS?

Factors that influence the EPS of Fredun Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Fredun Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in Fredun Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions